Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Annales De Radiologie
|
January 1, 1979
[Lymphography in malignant dysembryomas of the testis. Radio-anatomical comparison based on 40 lymph node dissections (author's transl)]
J L Chassard, J Papillon, D Serin, et al.
Bulletin Du Cancer
|
October 1, 1998
[Chemoprevention of cancer of the breast. Position statement on July 3, 1998 of the Fédŕation Nationale des Centres de Lutte Contre le Cancer (FNCLCC)]
F Eisinger, M Espié, F Kuttenn, et al.
Bulletin Du Cancer
|
July 1, 1993
[Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination]
B Chevallier, M Spielmann, M Marty, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
B Thürlimann, R Paridaens, D Serin, et al.
International Journal of Medical Sciences
|
June 21, 2008
Breast cancer screening in France: results of the EDIFICE survey
X Pivot, O Rixe, Jf Morere, et al.
Drugs
|
January 1, 1993
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group
J P Gérard, M Héry, D Gedouin, et al.
Acta Endocrinologica
|
September 1, 1982
Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas
X Bertagna, L Pique, C Ochoa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
H Roché, P Kerbrat, J Bonneterre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 25, 2006
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]
A Toledano, P Garaud, D Serin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
C Delbaldo, D Serin, M Mousseau, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Annales De Radiologie
|
January 1, 1979
[Lymphography in malignant dysembryomas of the testis. Radio-anatomical comparison based on 40 lymph node dissections (author's transl)]
J L Chassard, J Papillon, D Serin, et al.
Bulletin Du Cancer
|
October 1, 1998
[Chemoprevention of cancer of the breast. Position statement on July 3, 1998 of the Fédŕation Nationale des Centres de Lutte Contre le Cancer (FNCLCC)]
F Eisinger, M Espié, F Kuttenn, et al.
Bulletin Du Cancer
|
July 1, 1993
[Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination]
B Chevallier, M Spielmann, M Marty, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
B Thürlimann, R Paridaens, D Serin, et al.
International Journal of Medical Sciences
|
June 21, 2008
Breast cancer screening in France: results of the EDIFICE survey
X Pivot, O Rixe, Jf Morere, et al.
Drugs
|
January 1, 1993
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group
J P Gérard, M Héry, D Gedouin, et al.
Acta Endocrinologica
|
September 1, 1982
Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas
X Bertagna, L Pique, C Ochoa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
H Roché, P Kerbrat, J Bonneterre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 25, 2006
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]
A Toledano, P Garaud, D Serin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
C Delbaldo, D Serin, M Mousseau, et al.
Page
of 7